1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Artery Stenosis Global Clinical Trials Review, H1, 2015

Artery Stenosis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Artery Stenosis Global Clinical Trials Review, H1, 2015" provides data on the Artery Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Artery Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Artery Stenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Artery Stenosis Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Artery Stenosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Artery Stenosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Artery Stenosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Artery Stenosis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Artery Stenosis Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Abbott Laboratories 32
Clinical Trial Overview of Abbott Laboratories 32
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
CardioVascular BioTherapeutics, Inc. 35
Clinical Trial Overview of CardioVascular BioTherapeutics, Inc. 35
Bracco S.p.A. 36
Clinical Trial Overview of Bracco S.p.A. 36
Archemix Corp. 37
Clinical Trial Overview of Archemix Corp. 37
AMAG Pharmaceuticals, Inc. 38
Clinical Trial Overview of AMAG Pharmaceuticals, Inc. 38
advanceCor GmbH 39
Clinical Trial Overview of advanceCor GmbH 39
Clinical Trial Overview of Top Institutes / Government 40
Gifu University School of Medicine 40
Clinical Trial Overview of Gifu University School of Medicine 40
Mayo Clinic 41
Clinical Trial Overview of Mayo Clinic 41
Asan Medical Center 42
Clinical Trial Overview of Asan Medical Center 42
Emory University 43
Clinical Trial Overview of Emory University 43
Gifu University 44
Clinical Trial Overview of Gifu University 44
National Heart, Lung, and Blood Institute 45
Clinical Trial Overview of National Heart, Lung, and Blood Institute 45
University of Oxford 46
Clinical Trial Overview of University of Oxford 46
Asahikawa Medical University Hospital 47
Clinical Trial Overview of Asahikawa Medical University Hospital 47
Azienda Ospedaliera di Perugia 48
Clinical Trial Overview of Azienda Ospedaliera di Perugia 48
Azienda Ospedaliera S. Anna 49
Clinical Trial Overview of Azienda Ospedaliera S. Anna 49
Five Key Clinical Profiles 50
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 75

List of Tables
Artery Stenosis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Artery Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Artery Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Artery Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Artery Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Artery Stenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Artery Stenosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Artery Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Artery Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Artery Stenosis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Artery Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Artery Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Artery Stenosis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Artery Stenosis Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Artery Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Artery Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Artery Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Artery Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Artery Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 32
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 33
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 34
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CardioVascular BioTherapeutics, Inc., 2015* 35
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bracco S.p.A., 2015* 36
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Archemix Corp., 2015* 37
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AMAG Pharmaceuticals, Inc., 2015* 38
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by advanceCor GmbH, 2015* 39
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gifu University School of Medicine, 2015* 40
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 41
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 42
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015* 43
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gifu University, 2015* 44
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015* 45
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015* 46
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asahikawa Medical University Hospital, 2015* 47
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera di Perugia, 2015* 48
Artery Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera S. Anna, 2015* 49

List of Figures
Artery Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Artery Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Artery Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Artery Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Artery Stenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Artery Stenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Artery Stenosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Artery Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Artery Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Artery Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Artery Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Artery Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Artery Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Artery Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Artery Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Artery Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Artery Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

  • $ 5274
  • Industry report
  • September 2016
  • by Industry ARC

Pharmacovigilance is referred to as a practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.